These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 21326023)

  • 1. Retrospective comparison of diabetic foot ulcer and venous stasis ulcer healing outcome between a dermal repair scaffold (PriMatrix) and a bilayered living cell therapy (Apligraf).
    Karr JC
    Adv Skin Wound Care; 2011 Mar; 24(3):119-25. PubMed ID: 21326023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utilization of living bilayered cell therapy (Apligraf) for heel ulcers.
    Karr J
    Adv Skin Wound Care; 2008 Jun; 21(6):270-4. PubMed ID: 18525250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Best-practice algorithms for the use of a bilayered living cell therapy (Apligraf) in the treatment of lower-extremity ulcers.
    Cavorsi J; Vicari F; Wirthlin DJ; Ennis W; Kirsner R; O'Connell SM; Steinberg J; Falanga V
    Wound Repair Regen; 2006; 14(2):102-9. PubMed ID: 16630097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apligraf in the treatment of neuropathic diabetic foot ulcers.
    Edmonds M;
    Int J Low Extrem Wounds; 2009 Mar; 8(1):11-8. PubMed ID: 19189997
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innovative therapies in wound healing.
    Shen JT; Falanga V
    J Cutan Med Surg; 2003; 7(3):217-24. PubMed ID: 12704530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of bioengineered skin substitutes on diabetic foot ulcer and venous leg ulcer outcomes.
    Barber C; Watt A; Pham C; Humphreys K; Penington A; Mutimer K; Edwards M; Maddern G
    J Wound Care; 2008 Dec; 17(12):517-27. PubMed ID: 19052516
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Apligraf persistence and basement membrane restoration in donor site wounds: a pilot study.
    Hu S; Kirsner RS; Falanga V; Phillips T; Eaglstein WH
    Wound Repair Regen; 2006; 14(4):427-33. PubMed ID: 16939570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bilayered bioengineered skin substitute (Apligraf): a review of its use in the treatment of venous leg ulcers and diabetic foot ulcers.
    Curran MP; Plosker GL
    BioDrugs; 2002; 16(6):439-55. PubMed ID: 12463767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experience with the use of apligraf to heal complicated surgical and nonsurgical wounds in a private practice setting.
    Shealy FG; DeLoach ED
    Adv Skin Wound Care; 2006; 19(6):310-22. PubMed ID: 16885645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Wound healing in venous ulcers; mechanisms, approach and modern developments].
    Gibbs S; van den Hoogenband HM; de Boer EM
    Ned Tijdschr Geneeskd; 2007 Mar; 151(11):635-40. PubMed ID: 17441566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tissue engineering in wound repair.
    Falanga VJ
    Adv Skin Wound Care; 2000; 13(2 Suppl):15-9. PubMed ID: 11074998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apligraf living skin equivalent for healing venous and chronic wounds.
    Sibbald RG
    J Cutan Med Surg; 1998 Dec; 3 Suppl 1():S1-24-8. PubMed ID: 10082604
    [No Abstract]   [Full Text] [Related]  

  • 13. Wound bed score and its correlation with healing of chronic wounds.
    Falanga V; Saap LJ; Ozonoff A
    Dermatol Ther; 2006; 19(6):383-90. PubMed ID: 17199681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of Apligraf in the treatment of venous leg ulcers.
    Dolynchuk K; Hull P; Guenther L; Sibbald RG; Brassard A; Cooling M; Delorme L; Gulliver W; Bourassa DH; Ho V; Kunimoto B; Overholt T; Papp K; Tousignant J
    Ostomy Wound Manage; 1999 Jan; 45(1):34-43. PubMed ID: 10085970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tissue engineered skin: Apligraf, a bi-layered living skin equivalent.
    Trent JF; Kirsner RS
    Int J Clin Pract; 1998 Sep; 52(6):408-13. PubMed ID: 9894378
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healing of elderly patients with diabetic foot ulcers, venous stasis ulcers, and pressure ulcers.
    Brem H; Tomic-Canic M; Tarnovskaya A; Ehrlich HP; Baskin-Bey E; Gill K; Carasa M; Weinberger S; Entero H; Vladeck B
    Surg Technol Int; 2003; 11():161-7. PubMed ID: 12931298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of an acellular flowable dermal replacement scaffold on lower extremity sinus tract wounds: a retrospective series.
    Brigido SA; Schwartz E; McCarroll R; Hardin-Young J
    Foot Ankle Spec; 2009 Apr; 2(2):67-72. PubMed ID: 19825754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers.
    Langer A; Rogowski W
    BMC Health Serv Res; 2009 Jul; 9():115. PubMed ID: 19591680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of graftskin (Apligraf) in difficult-to-heal venous leg ulcers.
    Bello YM; Falabella AF
    J Wound Care; 2002 May; 11(5):182-3. PubMed ID: 12055943
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ulcus cruris and other problem cases. How suppurative wounds heal].
    Neumaier J
    MMW Fortschr Med; 2004 Feb; 146(6):4-6. PubMed ID: 15035302
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.